NCT03295864View on ClinicalTrials.gov

Arnold Chiari Malformation: the Otological Assessment as an Objective Criteria for Surgical Treatment

NACompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 20, 2017

Primary Completion Date

February 17, 2020

Study Completion Date

February 17, 2020

Conditions
Arnold-Chiari Malformation, Type 1
Interventions
DIAGNOSTIC_TEST

Multifrequency tympanometry at Inclusion

Multifrequency tympanometry measurement and particularly width of conductance tympanograms at 2 kHz will be performed for both group at inclusion

DIAGNOSTIC_TEST

Multifrequency tympanometry 6 month after surgery

Multifrequency tympanometry measurement and particularly width of conductance tympanograms at 2 kHz will be performed 6 months after surgery for Chiari type I malformation patient

Trial Locations (1)

33076

CHU de Bordeaux, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT03295864 - Arnold Chiari Malformation: the Otological Assessment as an Objective Criteria for Surgical Treatment | Biotech Hunter | Biotech Hunter